Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

IVIg-induced plasmablasts in patients with Guillain-Barré syndrome.

Brem MD, Jacobs BC, van Rijs W, Fokkink WJR, Tio-Gillen AP, Walgaard C, van Doorn PA, IJspeert H, van der Burg M, Huizinga R.

Ann Clin Transl Neurol. 2018 Nov 27;6(1):129-143. doi: 10.1002/acn3.687. eCollection 2019 Jan.

2.

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.

Rovin BH, Solomons N, Pendergraft WF 3rd, Dooley MA, Tumlin J, Romero-Diaz J, Lysenko L, Navarra SV, Huizinga RB; AURA-LV Study Group.

Kidney Int. 2019 Jan;95(1):219-231. doi: 10.1016/j.kint.2018.08.025. Epub 2018 Nov 9.

PMID:
30420324
3.

Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae.

Meyer Sauteur PM, de Bruijn ACJM, Graça C, Tio-Gillen AP, Estevão SC, Hoogenboezem T, Hendriks RW, Berger C, Jacobs BC, van Rossum AMC, Huizinga R, Unger WWJ.

Infect Immun. 2019 Jan 24;87(2). pii: e00663-18. doi: 10.1128/IAI.00663-18. Print 2019 Feb.

PMID:
30396892
4.

Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.

Taams NE, Notermans NC, Fokkink WR, Tio-Gillen AP, Huizinga R, Schreurs MWJ, Jacobs BC.

J Peripher Nerv Syst. 2018 Dec;23(4):227-234. doi: 10.1111/jns.12285. Epub 2018 Sep 12.

PMID:
30101437
5.

TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.

Bodewes ILA, Huijser E, van Helden-Meeuwsen CG, Tas L, Huizinga R, Dalm VASH, van Hagen PM, Groot N, Kamphuis S, van Daele PLA, Versnel MA.

J Autoimmun. 2018 Jul;91:97-102. doi: 10.1016/j.jaut.2018.02.001. Epub 2018 Apr 16.

PMID:
29673738
6.

Intrathecal antibody responses to GalC in Guillain-Barré syndrome triggered by Mycoplasma pneumoniae.

Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, Drenthen J, Unger WWJ, Jacobs E, van Rossum AMC, Jacobs BC.

J Neuroimmunol. 2018 Jan 15;314:13-16. doi: 10.1016/j.jneuroim.2017.11.011. Epub 2017 Nov 16.

PMID:
29301655
7.

Antibody responses to GalC in severe and complicated childhood Guillain-Barré syndrome.

Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, de Wit MY, Unger WWJ, Berger C, van Rossum AMC, Jacobs BC.

J Peripher Nerv Syst. 2018 Mar;23(1):67-69. doi: 10.1111/jns.12243. No abstract available.

8.

Immunotherapy Added to Antibiotic Treatment Reduces Relapse of Disease in a Mouse Model of Tuberculosis.

Mourik BC, Leenen PJ, de Knegt GJ, Huizinga R, van der Eerden BC, Wang J, Krois CR, Napoli JL, Bakker-Woudenberg IA, de Steenwinkel JE.

Am J Respir Cell Mol Biol. 2017 Feb;56(2):233-241. doi: 10.1165/rcmb.2016-0185OC.

PMID:
27654457
9.

Mycoplasma pneumoniae triggering the Guillain-Barré syndrome: A case-control study.

Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, Roodbol J, Hoogenboezem T, Jacobs E, van Rijn M, van der Eijk AA, Vink C, de Wit MC, van Rossum AM, Jacobs BC.

Ann Neurol. 2016 Oct;80(4):566-80. doi: 10.1002/ana.24755. Epub 2016 Aug 26.

PMID:
27490360
10.

Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS.

Fokkink WJ, Haarman AE, Tio-Gillen AP, van Rijs W, Huizinga R, van Doorn PA, Jacobs BC.

Ann Clin Transl Neurol. 2016 May 17;3(7):547-51. doi: 10.1002/acn3.307. eCollection 2016 Jul. Erratum in: Ann Clin Transl Neurol. 2017 Jan 09;4(1):71.

11.

Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G.

Fokkink WJ, Falck D, Santbergen TC, Huizinga R, Wuhrer M, Jacobs BC.

PLoS One. 2015 Oct 12;10(10):e0139828. doi: 10.1371/journal.pone.0139828. eCollection 2015.

12.

Campylobacter jejuni capsular genotypes are related to Guillain-Barré syndrome.

Heikema AP, Islam Z, Horst-Kreft D, Huizinga R, Jacobs BC, Wagenaar JA, Poly F, Guerry P, van Belkum A, Parker CT, Endtz HP.

Clin Microbiol Infect. 2015 Sep;21(9):852.e1-9. doi: 10.1016/j.cmi.2015.05.031. Epub 2015 Jun 9.

13.

Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome.

Huizinga R, van den Berg B, van Rijs W, Tio-Gillen AP, Fokkink WJ, Bakker-Jonges LE, Geleijns K, Samsom JN, van Doorn PA, Laman JD, Jacobs BC.

Ann Neurol. 2015 Sep;78(3):343-54. doi: 10.1002/ana.24442. Epub 2015 Jun 30.

PMID:
26017721
14.

Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells.

Franquesa M, Mensah FK, Huizinga R, Strini T, Boon L, Lombardo E, DelaRosa O, Laman JD, Grinyó JM, Weimar W, Betjes MG, Baan CC, Hoogduijn MJ.

Stem Cells. 2015 Mar;33(3):880-91. doi: 10.1002/stem.1881.

15.

IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.

Fokkink WJ, Selman MH, Dortland JR, Durmuş B, Kuitwaard K, Huizinga R, van Rijs W, Tio-Gillen AP, van Doorn PA, Deelder AM, Wuhrer M, Jacobs BC.

J Proteome Res. 2014 Mar 7;13(3):1722-30. doi: 10.1021/pr401213z. Epub 2014 Feb 17.

PMID:
24533874
16.

Cytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporin.

Ling SY, Huizinga RB, Mayo PR, Larouche R, Freitag DG, Aspeslet LJ, Foster RT.

Br J Clin Pharmacol. 2014 Jun;77(6):1039-50. doi: 10.1111/bcp.12309.

17.

Population PKPD of voclosporin in renal allograft patients.

Mayo PR, Ling SY, Huizinga RB, Freitag DG, Aspeslet LJ, Foster RT.

J Clin Pharmacol. 2014 May;54(5):537-45. doi: 10.1002/jcph.237. Epub 2013 Nov 30.

PMID:
24243422
18.

Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-α.

Huizinga R, van Rijs W, Bajramovic JJ, Kuijf ML, Laman JD, Samsom JN, Jacobs BC.

J Immunol. 2013 Dec 1;191(11):5636-45. doi: 10.4049/jimmunol.1301536. Epub 2013 Oct 28.

19.

Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.

Puentes F, van der Star BJ, Victor M, Kipp M, Beyer C, Peferoen-Baert R, Ummenthum K, Pryce G, Gerritsen W, Huizinga R, Reijerkerk A, van der Valk P, Baker D, Amor S.

J Neuroinflammation. 2013 Sep 22;10:118. doi: 10.1186/1742-2094-10-118.

20.

Pharmacokinetics of voclosporin in renal impairment and hepatic impairment.

Ling SY, Huizinga RB, Mayo PR, Freitag DG, Aspeslet LJ, Foster RT.

J Clin Pharmacol. 2013 Dec;53(12):1303-12. doi: 10.1002/jcph.166. Epub 2013 Oct 8.

PMID:
23996158
21.

Voclosporin food effect and single oral ascending dose pharmacokinetic and pharmacodynamic studies in healthy human subjects.

Mayo PR, Huizinga RB, Ling SY, Freitag DG, Aspeslet LJ, Foster RT.

J Clin Pharmacol. 2013 Aug;53(8):819-26. doi: 10.1002/jcph.114. Epub 2013 Jun 4.

PMID:
23736966
22.

Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.

Huizinga R, Kreft KL, Onderwater S, Boonstra JG, Brands R, Hintzen RQ, Laman JD.

J Neuroinflammation. 2012 Dec 11;9:266. doi: 10.1186/1742-2094-9-266.

23.

Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome.

Heikema AP, Jacobs BC, Horst-Kreft D, Huizinga R, Kuijf ML, Endtz HP, Samsom JN, van Wamel WJ.

Clin Microbiol Infect. 2013 Feb;19(2):E106-12. doi: 10.1111/1469-0691.12073. Epub 2012 Nov 23.

24.

Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease.

Koole D, Hurks R, Schoneveld A, Vink A, Golledge J, Moran CS, de Kleijn DP, van Herwaarden JA, de Vries JP, Laman JD, Huizinga R, Pasterkamp G, Moll FL.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1497-504. doi: 10.1161/ATVBAHA.111.243592. Epub 2012 Apr 19.

PMID:
22516062
25.

Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice.

Huizinga R, Easton AS, Donachie AM, Guthrie J, van Rijs W, Heikema A, Boon L, Samsom JN, Jacobs BC, Willison HJ, Goodyear CS.

PLoS One. 2012;7(3):e34416. doi: 10.1371/journal.pone.0034416. Epub 2012 Mar 28.

26.

Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis.

Huizinga R, van der Star BJ, Kipp M, Jong R, Gerritsen W, Clarner T, Puentes F, Dijkstra CD, van der Valk P, Amor S.

Glia. 2012 Mar;60(3):422-31. doi: 10.1002/glia.22276. Epub 2011 Dec 9.

PMID:
22161990
27.

The PROMISE study: a phase 2b multicenter study of voclosporin (ISA247) versus tacrolimus in de novo kidney transplantation.

Busque S, Cantarovich M, Mulgaonkar S, Gaston R, Gaber AO, Mayo PR, Ling S, Huizinga RB, Meier-Kriesche HU; PROMISE Investigators.

Am J Transplant. 2011 Dec;11(12):2675-84. doi: 10.1111/j.1600-6143.2011.03763.x. Epub 2011 Sep 22.

28.

TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.

Kuijf ML, Samsom JN, van Rijs W, Bax M, Huizinga R, Heikema AP, van Doorn PA, van Belkum A, van Kooyk Y, Burgers PC, Luider TM, Endtz HP, Nieuwenhuis EE, Jacobs BC.

J Immunol. 2010 Jul 1;185(1):748-55. doi: 10.4049/jimmunol.0903014. Epub 2010 Jun 4.

29.

ISA247: quality of life results from a phase II, randomized, placebo-controlled study.

Gupta AK, Langley RG, Lynde C, Barber K, Gulliver W, Lauzon G, Aspeslet LJ, Foster RT, Huizinga RB, Yatscoff RW.

J Cutan Med Surg. 2008 Nov-Dec;12(6):268-75.

PMID:
19317948
30.

T-cell responses to neurofilament light protein are part of the normal immune repertoire.

Huizinga R, Hintzen RQ, Assink K, van Meurs M, Amor S.

Int Immunol. 2009 Apr;21(4):433-41. doi: 10.1093/intimm/dxp011. Epub 2009 Feb 24.

PMID:
19240089
31.

Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE.

van Zwam M, Huizinga R, Melief MJ, Wierenga-Wolf AF, van Meurs M, Voerman JS, Biber KP, Boddeke HW, Höpken UE, Meisel C, Meisel A, Bechmann I, Hintzen RQ, 't Hart BA, Amor S, Laman JD, Boven LA.

J Mol Med (Berl). 2009 Mar;87(3):273-86. doi: 10.1007/s00109-008-0421-4. Epub 2008 Dec 3.

PMID:
19050840
32.

Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.

van Zwam M, Huizinga R, Heijmans N, van Meurs M, Wierenga-Wolf AF, Melief MJ, Hintzen RQ, 't Hart BA, Amor S, Boven LA, Laman JD.

J Pathol. 2009 Mar;217(4):543-51. doi: 10.1002/path.2476.

PMID:
19023878
33.

Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments.

Huizinga R, Gerritsen W, Heijmans N, Amor S.

Neurobiol Dis. 2008 Dec;32(3):461-70. doi: 10.1016/j.nbd.2008.08.009. Epub 2008 Sep 4.

PMID:
18804534
34.

Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study.

Papp K, Bissonnette R, Rosoph L, Wasel N, Lynde CW, Searles G, Shear NH, Huizinga RB, Maksymowych WP.

Lancet. 2008 Apr 19;371(9621):1337-42. doi: 10.1016/S0140-6736(08)60593-0.

PMID:
18424323
35.

Resistance is futile: antineuronal autoimmunity in multiple sclerosis.

Huizinga R, Linington C, Amor S.

Trends Immunol. 2008 Feb;29(2):54-60. doi: 10.1016/j.it.2007.11.002. Epub 2008 Jan 7.

PMID:
18182323
36.

Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH mice.

Huizinga R, Heijmans N, Schubert P, Gschmeissner S, 't Hart BA, Herrmann H, Amor S.

J Neuropathol Exp Neurol. 2007 Apr;66(4):295-304.

PMID:
17413320
37.

A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis.

Bissonnette R, Papp K, Poulin Y, Lauzon G, Aspeslet L, Huizinga R, Mayo P, Foster RT, Yatscoff RW, Maksymowych WP; ISA247 Psoriasis Study Group.

J Am Acad Dermatol. 2006 Mar;54(3):472-8. Epub 2006 Jan 23.

PMID:
16488299
38.

Nephrology and the Internet.

Huizinga R.

CANNT J. 2000 Jan-Mar;10(1):55. No abstract available.

PMID:
15719605
39.

Nephrology and the Internet.

Huizinga R.

CANNT J. 1999 Summer;9(3):16. No abstract available.

PMID:
15712467
40.

New paradigms in immunosuppression.

Huizinga R, Voyer T.

CANNT J. 2003 Jul-Sep;13(3):66-8. Review.

PMID:
14596200
41.

Update in immunosuppression.

Huizinga R.

Nephrol Nurs J. 2002 Jun;29(3):261-7. Review.

PMID:
12164076
42.

Nephrology and the Internet--personal digital assistants.

Huizinga RB.

CANNT J. 2001 Jul-Sep;11(3):52. No abstract available.

PMID:
11785194
43.

Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro.

Van der Goes A, Wouters D, Van Der Pol SM, Huizinga R, Ronken E, Adamson P, Greenwood J, Dijkstra CD, De Vries HE.

FASEB J. 2001 Aug;15(10):1852-4. No abstract available.

PMID:
11481252
44.

Iron saturation of ferritin in the course of phlebotomy treatment in patients with haemochromatosis.

ten Kate J, Marell K, Huizinga R, Kreeftenberg H, van Deursen C.

Clin Chem Lab Med. 1999 Aug;37(8):827-30.

PMID:
10536932
45.

Nephrology and the Internet.

Huizinga R.

J CANNT. 1998 Fall;8(4):17. No abstract available.

PMID:
10196926
46.

Nephrology and the Internet.

Huizinga R.

J CANNT. 1998 Summer;8(3):17. No abstract available.

PMID:
9807321
47.

Security on the Web: Big Brother is watching you.

Huizinga R, Berry M.

AARN News Lett. 1997 Jun;53(6):15. No abstract available.

PMID:
9306762
48.

Everything you need to know to play in the global sandbox.

Huizinga R, Berry M.

AARN News Lett. 1997 May;53(5):25, 32. No abstract available.

PMID:
9306758
49.

Where have we been?

Huizinga R, Berry M.

AARN News Lett. 1997 Apr;53(4):13. No abstract available.

PMID:
9306748
50.

The power of your Web browser.

Huizinga R, Berry M.

AARN News Lett. 1997 Mar;53(3):23, 32. No abstract available.

PMID:
9306769

Supplemental Content

Loading ...
Support Center